Theodore Karrison

Affiliated with

Research Area

Biography

Theodore Karrison has not added Biography.
If you are Theodore Karrison and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 5	2011

Other Publications

Article	Year
Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial. The Journal of pharmacology and experimental therapeutics\| PubMed ID: 11752106	2002
Sizes of ruptured and unruptured aneurysms in relation to their sites and the ages of patients. Journal of neurosurgery\| PubMed ID: 11794606	2002
Data management and statistical methods used in the analysis of balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and therapy-related acute leukemia: report from... Genes, chromosomes & cancer\| PubMed ID: 11921270	2002
Evaluation of the direct antiglobulin (Coombs') test for identifying newborns at risk for hemolysis as determined by end-tidal carbon monoxide concentration (ETCOc); and comparison of the Co... Journal of perinatology : official journal of the California Perinatal Association\| PubMed ID: 12082466	2002
Isoimmunization is unlikely to be the cause of hemolysis in ABO-incompatible but direct antiglobulin test-negative neonates. Pediatrics\| PubMed ID: 12093957	2002
Troxacitabine in patients with refractory leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 12149312	2002
Determination of the optimal modulatory dose of O6-benzylguanine in patients with surgically resectable tumors. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 12171878	2002
Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Cancer research\| PubMed ID: 12438272	2002
Predictors of emergency medical services utilization by elders. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine\| PubMed ID: 12511315	2003
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood\| PubMed ID: 12623843	2003
The aspect ratio (dome/neck) of ruptured and unruptured aneurysms. Journal of neurosurgery\| PubMed ID: 12959428	2003
A group sequential, response-adaptive design for randomized clinical trials. Controlled clinical trials\| PubMed ID: 14500050	2003
Long-term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis: a prospective observational study. Annals of surgery\| PubMed ID: 14501509	2003
Prognostic factors for survival with gemcitabine plus 5-fluorouracil based regimens for metastatic renal cancer. The Journal of urology\| PubMed ID: 14501711	2003
Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage. Journal of neurosurgery\| PubMed ID: 14567598	2003
A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma. Cancer\| PubMed ID: 14692025	2004
Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer research\| PubMed ID: 14996737	2004
Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 15007088	2004
Strong synergy between mutant ras and HPV16 E6/E7 in the development of primary tumors. Oncogene\| PubMed ID: 15077191	2004
9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University ... Investigational new drugs\| PubMed ID: 15122080	2004
A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 15161690	2004
Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial. Annals of internal medicine\| PubMed ID: 15238367	2004
Fetal loss associated with excess thyroid hormone exposure. JAMA : the journal of the American Medical Association\| PubMed ID: 15304465	2004
The human BCL6 transgene promotes the development of lymphomas in the mouse. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 15375218	2004
Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 15570084	2004
Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanine. Cancer chemotherapy and pharmacology\| PubMed ID: 15723259	2005
Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans. Journal of clinical pharmacology\| PubMed ID: 15831777	2005
Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer research\| PubMed ID: 15833844	2005
Studies in hemolysis in glucose-6-phosphate dehydrogenase-deficient African American neonates. Clinica chimica acta; international journal of clinical chemistry\| PubMed ID: 16188248	2006
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 16258101	2005
Gene expression profiles in acute myeloid leukemia with common translocations using SAGE. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 16418266	2006
A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma. Investigational new drugs\| PubMed ID: 16514482	2006
Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 16619149	2006
A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer. Cancer biology & therapy\| PubMed ID: 16760642	2006
Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies. Pediatrics\| PubMed ID: 16864640	2006
Continuous Bayesian adaptive randomization based on event times with covariates by Cheung et al., Statistics in Medicine 2006; 25:55-70. Statistics in medicine\| PubMed ID: 17163577	2007
Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant. American journal of clinical pathology\| PubMed ID: 17210514	2007
Testing the wrong hypothesis in phase II oncology trials: there is a better alternative. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 17289865	2007
A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinoma. Cancer biology & therapy\| PubMed ID: 17457044	2007
Whole blood viscosity and arterial thrombotic events in patients with systemic lupus erythematosus. Arthritis and rheumatism\| PubMed ID: 17530685	2007
Safety and tolerability of Ganoderma lucidum in healthy subjects: a double-blind randomized placebo-controlled trial. The American journal of Chinese medicine\| PubMed ID: 17597499	2007
Critical evaluation of diagnostic aids for the detection of oral cancer. Oral oncology\| PubMed ID: 17825602	2008
Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer. Journal of the National Cancer Institute\| PubMed ID: 17895472	2007
Reproducibility and sources of variability in radiographic texture analysis of densitometric calcaneal images. Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry\| PubMed ID: 18158263	2008
Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid l... Investigational new drugs\| PubMed ID: 18217206	2008
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, a... Leukemia & lymphoma\| PubMed ID: 18297531	2008
Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 18309947	2008
IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers. The Journal of clinical investigation\| PubMed ID: 18317595	2008
A phase I and pharmacokinetic study of the quinoxaline antitumour Agent R(+)XK469 in patients with advanced solid tumours. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 18650079	2008
Modeling major lung resection outcomes using classification trees and multiple imputation techniques. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery\| PubMed ID: 18760930	2008
Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 18824708	2008
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study. The lancet oncology\| PubMed ID: 19201650	2009
A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 19228743	2009
A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer. European urology\| PubMed ID: 19282098	2009
Design of Phase II cancer trials for evaluation of cytostatic/cytotoxic agents. Journal of biopharmaceutical statistics\| PubMed ID: 19384693	2009
What does it cost physician practices to interact with health insurance plans? Health affairs (Project Hope)\| PubMed ID: 19443477	2009
Frequency of failure to inform patients of clinically significant outpatient test results. Archives of internal medicine\| PubMed ID: 19546413	2009
Phase II study of sunitinib malate in head and neck squamous cell carcinoma. Investigational new drugs\| PubMed ID: 19649772	2010
Common fragile sites are characterized by histone hypoacetylation. Human molecular genetics\| PubMed ID: 19717471	2009
Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 19773379	2009
Impaired replication dynamics at the FRA3B common fragile site. Human molecular genetics\| PubMed ID: 19815620	2010
Neoplasms with schwannian differentiation express transcription factors known to regulate normal schwann cell development. International journal of surgical pathology\| PubMed ID: 20034979	2010
CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases. PloS one\| PubMed ID: 20126411	2010
A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma. American journal of clinical oncology\| PubMed ID: 20395787	2011
Statin use and risk of prostate cancer recurrence in men treated with radiation therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 20421534	2010
Outcomes in black patients with early breast cancer treated with breast conservation therapy. International journal of radiation oncology, biology, physics\| PubMed ID: 20434849	2011
Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 20837940	2010
A phase I study of continuous infusion cilengitide in patients with solid tumors. Investigational new drugs\| PubMed ID: 20839028	2012
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma. Cancer biology & therapy\| PubMed ID: 21543897	2011
Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database. Journal of clinical bioinformatics\| PubMed ID: 21603121	2011
The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patients. Cancer chemotherapy and pharmacology\| PubMed ID: 21861128	2011
Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 22021924	2011
Targeted and Cytotoxic Therapy in Coordinated Sequence (TACTICS): Erlotinib, Bevacizumab, and Standard Chemotherapy for Non-Small-Cell Lung Cancer, A Phase II Trial. Clinical lung cancer\| PubMed ID: 22100149	2011
MET and phosphorylated MET as potential biomarkers in lung cancer. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer\| PubMed ID: 22181983	2011
Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity. Obstetrics and gynecology\| PubMed ID: 22183212	2012
Resampling phase III data to assess phase II trial designs and endpoints. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 22287601	2012